相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between H1N1 vaccination and narcolepsy-cataplexy Flu to sleep
Sanjeev V. Kothare et al.
NEUROLOGY (2013)
Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells
Amy S. McKee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns
Leonoor Wijnans et al.
VACCINE (2013)
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability
Elena Feshchenko et al.
BMC BIOTECHNOLOGY (2012)
A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
Yufei Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
A Vero Cell-Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
Richard Fritz et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
GLA-SE, a Synthetic Toll-like Receptor 4 Agonist, Enhances T-Cell Responses to Influenza Vaccine in Older Adults
Hayedeh Behzad et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases
Adriana Baz Morelli et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
AF03, an alternative squalene emulsion-based vaccine adjuvant prepared by a phase inversion temperature method
Marie-Francoise Klucker et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Adjuvant solution for pandemic influenza vaccine production
Christopher H. Clegg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Sander Herfst et al.
SCIENCE (2012)
Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections
Ge Liu et al.
VACCINE (2012)
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
David N. Taylor et al.
VACCINE (2012)
The mechanism of action of MF59 - An innately attractive adjuvant formulation
D. T. O'Hagan et al.
VACCINE (2012)
Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
Jessica A. Chichester et al.
VIRUSES-BASEL (2012)
Overview of global regulatory toxicology requirements for vaccines and adjuvants
Yuansheng Sun et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
New Strategies for the Development of H5N1 Subtype Influenza Vaccines Progress and Challenges
John Steel
BIODRUGS (2011)
Use of defined TLR ligands as adjuvants within human vaccines
Malcolm S. Duthie et al.
IMMUNOLOGICAL REVIEWS (2011)
Influenza vaccine immunology
Philip R. Dormitzer et al.
IMMUNOLOGICAL REVIEWS (2011)
Hallmarks of CD4 T cell immunity against influenza
K. K. McKinstry et al.
JOURNAL OF INTERNAL MEDICINE (2011)
Bacterial HA1 Vaccine against Pandemic H5N1 Influenza Virus: Evidence of Oligomerization, Hemagglutination, and Cross-Protective Immunity in Ferrets
Surender Khurana et al.
JOURNAL OF VIROLOGY (2011)
H5N1 Virus-Like Particle Vaccine Elicits Cross-Reactive Neutralizing Antibodies That Preferentially Bind to the Oligomeric Form of Influenza Virus Hemagglutinin in Humans
Surender Khurana et al.
JOURNAL OF VIROLOGY (2011)
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Tracy L. Flach et al.
NATURE MEDICINE (2011)
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
Rhea N. Coler et al.
PLOS ONE (2011)
Assessing the Safety of Adjuvanted Vaccines
S. Sohail Ahmed et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines
Surender Khurana et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17–18 February 2011
Marc P. Girard et al.
VACCINE (2011)
H5N1 Avian Influenza: Preventive and Therapeutic Strategies Against a Pandemic
Suryaprakash Sambhara et al.
ANNUAL REVIEW OF MEDICINE (2010)
A Phase III, Randomized, Open-Label Study to Assess the Tolerability and Immunogenicity of an H5N1 Influenza Vaccine Administered to Healthy Adults With a 1-, 2-, 3-, or 6-Week Interval Between First and Second Doses
Jiri Beran et al.
CLINICAL THERAPEUTICS (2010)
Vaccination, squalene and anti-squalene antibodies: Facts or fiction?
Giuseppe Lippi et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2010)
The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza
Marc-Andre D'Aoust et al.
PLANT BIOTECHNOLOGY JOURNAL (2010)
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
Rhea N. Coler et al.
PLOS ONE (2010)
Preclinical and Clinical Development of Plant-Made Virus-Like Particle Vaccine against Avian H5N1 Influenza
Nathalie Landry et al.
PLOS ONE (2010)
Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
Timo Vesikari et al.
PEDIATRICS (2010)
Priming with AS03A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: An open non-randomised extension of a double-blind randomised primary study
Isabel Leroux-Roels et al.
VACCINE (2010)
The Inflammasomes: Guardians of the Body
Fablo Martinon et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Evaluation of Vaccines for H5N1 Influenza Virus in Ferrets Reveals the Potential for Protective Single-Shot Immunization
Deborah Middleton et al.
JOURNAL OF VIROLOGY (2009)
MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Angelika Banzhoff et al.
PLOS ONE (2009)
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
Grazia Galli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
B cells and aging: molecules and mechanisms
Michael P. Cancro et al.
TRENDS IN IMMUNOLOGY (2009)
New horizons in adjuvants for vaccine development
Steven G. Reed et al.
TRENDS IN IMMUNOLOGY (2009)
Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults
Tino F. Schwarz et al.
VACCINE (2009)
Enhanced humoral and Type 1 cellular immune responses with Fluzone® adjuvanted with a synthetic TLR4 agonist formulated in an emulsion
Susan L. Baldwin et al.
VACCINE (2009)
MF59-adjuvanted versus non-adjuvanted influenza vaccines: Integrated analysis from a large safety database
Michele Pellegrini et al.
VACCINE (2009)
The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus
Amorsolo L. Suguitan et al.
VIROLOGY (2009)
Towards an understanding of the adjuvant action of aluminium
Philippa Marrack et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Dual signaling of MyD88 and TRIF is critical for maximal TLR4-induced dendritic cell maturation
Hua Shen et al.
JOURNAL OF IMMUNOLOGY (2008)
An adjuvanted, low-dose, pandemic influenza a (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults
Karin Levie et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults
David I. Bernstein et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity
Yossef Raviv et al.
JOURNAL OF VIROLOGY (2008)
Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
Isabel Leroux-Roels et al.
PLOS ONE (2008)
Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
Rick A. Bright et al.
PLOS ONE (2008)
H5N1VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses
Kutubuddin Mahmood et al.
VACCINE (2008)
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
Terry M. Nolan et al.
VACCINE (2008)
Preparing for a possible pandemic: influenza A/H5N1 vaccine development
Wendy A. Keitel et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine:: a randomised controlled trial
Isabel Leroux-Roels et al.
LANCET (2007)
Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells
Sunil Kannanganat et al.
JOURNAL OF VIROLOGY (2007)
Avian and pandemic influenza: An overview
Gregory A. Poland et al.
VACCINE (2007)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice
AO Hovden et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
JJ Treanor et al.
VACCINE (2001)
分享论文
